Pharmesis International Ltd.
Research Pharmesis International Ltd. (BFK.SI) on Bullrun: market cap SGD 3.01M, dividend yield 10.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBFK.SI
- ExchangeSGX
- CountrySingapore
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencySGD
- Market capSGD 3.01M
- Dividend yield10.5%
- Financial periodFY2025
- RevenueCNY 43.75M
- Revenue growth-35.3%
- Net income-CNY 4.30M
- Free cash flowCNY 2.36M
- Gross margin36.2%
Valuation Snapshot
latest market cap is SGD 3.01M; dividend yield is 10.5%.
Peer valuation comparison
Latest dividend yield is 10.53% versus a Healthcare sector median of 2.4% (338.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 43.75M | -CNY 4.30M | CNY 2.36M | 36.2% | -0.14 | CNY 4.31M | CNY 15.70M | CNY 55.55M |
| FY2024 | CNY 67.65M | CNY 8.28M | -CNY 3.54M | 35.7% | 0.28 | CNY 4.60M | CNY 16.26M | CNY 61.57M |
| FY2023 | CNY 45.64M | -CNY 4.96M | -CNY 12.24M | 45.6% | -0.19 | CNY 9.48M | CNY 16.52M | CNY 51.07M |
| FY2022 | CNY 50.37M | -CNY 3.56M | CNY 6.33M | 47.7% | -0.16 | CNY 19.72M | CNY 16.53M | CNY 53.90M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | SGD 3.01M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SGD, yield 10.5%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.01 CNY |
About Pharmesis International Ltd.
Pharmesis International Ltd., an investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People's Republic of China. The company operates through three segments: Western drugs/TCH Procurement, TCM formulated drugs/IP Rental, and Distribution. It provides prescribed products and over-the-counter drugs.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Pharmesis International Ltd.'s market cap?
Pharmesis International Ltd.'s market capitalization is SGD 3.01M.
Does Pharmesis International Ltd. pay a dividend?
Pharmesis International Ltd. has a dividend yield of 10.5%.
What does Pharmesis International Ltd. do?
Pharmesis International Ltd., an investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People's Republic of China. The company operates through three segments: Western drugs/TCH Procurement, TCM formulated drugs/IP Rental, and Distribution. It provides prescribed products and over-the-counter drugs.